These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12227131)

  • 1. Aspirin in diabetic retinopathy. A systematic review.
    Bergerhoff K; Clar C; Richter B
    Endocrinol Metab Clin North Am; 2002 Sep; 31(3):779-93. PubMed ID: 12227131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Early Treatment Diabetic Retinopathy Study Research Group.
    Ophthalmology; 1991 May; 98(5 Suppl):757-65. PubMed ID: 2062511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controlled clinical trial of the effect of aspirin and aspirin + dipyridamole on the development of diabetic retinopathy. II. Ophthalmologic protocol].
    Diabete Metab; 1982 Dec; 8(4):307-11. PubMed ID: 6761186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. The DAMAD Study Group.
    Diabetes; 1989 Apr; 38(4):491-8. PubMed ID: 2647556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin at low-intermediate concentrations protects retinal vessels in experimental diabetic retinopathy through non-platelet-mediated effects.
    Sun W; Gerhardinger C; Dagher Z; Hoehn T; Lorenzi M
    Diabetes; 2005 Dec; 54(12):3418-26. PubMed ID: 16306357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin effects on the development of cataracts in patients with diabetes mellitus. Early treatment diabetic retinopathy study report 16.
    Chew EY; Williams GA; Burton TC; Barton FB; Remaley NA; Ferris FL
    Arch Ophthalmol; 1992 Mar; 110(3):339-42. PubMed ID: 1543449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggrenox: a fixed-dose combination of aspirin and dipyridamole.
    Lenz TL; Hilleman DE
    Ann Pharmacother; 2000 Nov; 34(11):1283-90. PubMed ID: 11098344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2006 Apr; (2):CD001820. PubMed ID: 16625549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early photocoagulation in patients with either type I or type II diabetes.
    Ferris F
    Trans Am Ophthalmol Soc; 1996; 94():505-37. PubMed ID: 8981711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy.
    Zheng L; Howell SJ; Hatala DA; Huang K; Kern TS
    Diabetes; 2007 Feb; 56(2):337-45. PubMed ID: 17259377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin, dipyridamole and platelet survival in patients with diabetes mellitus.
    Tindall H; Paton RC; McNicol GP
    Clin Sci (Lond); 1982 Aug; 63(2):205-9. PubMed ID: 7044655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin for diabetic retinopathy.
    Kohner EM
    BMJ; 2003 Nov; 327(7423):1060-1. PubMed ID: 14604902
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetic retinopathy and lipid abnormalities.
    Chew EY
    Curr Opin Ophthalmol; 1997 Jun; 8(3):59-62. PubMed ID: 10168895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2007 Jul; (3):CD001820. PubMed ID: 17636684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7.
    Ophthalmology; 1991 May; 98(5 Suppl):741-56. PubMed ID: 2062510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet and anticoagulation for patients with prosthetic heart valves.
    Little SH; Massel DR
    Cochrane Database Syst Rev; 2003; (4):CD003464. PubMed ID: 14583979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
    Jaturapatporn D; Isaac MG; McCleery J; Tabet N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy: a randomized clinical trial.
    Scott IU; Jackson GR; Quillen DA; Larsen M; Klein R; Liao J; Holfort S; Munch IC; Gardner TW
    JAMA Ophthalmol; 2014 May; 132(5):535-43. PubMed ID: 24604308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
    Colebatch AN; Marks JL; Edwards CJ
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008872. PubMed ID: 22071858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.